fashion -WSS

fashion

author：entertainment 2025-10-02 00:18:01 - browse：4

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Eating disorder hotline's move to chatbot carried cost for volunteers

WSS

'Reaching a detente': STAT's Helen Branswell on covering Covid

Brazil's Jair Bolsonaro is barred from running for office until 2030

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

ADA: All diabetes patients should be screened for liver condition

focus

fashion

leisure time

What does generative AI mean for health care? We asked experts

Couple fighting to bring baby home from Mexico are finally reunited

New air purifier tech could be key to improving indoor air quality

Medical experts exlpore how to eliminate bias in clinical algorithms

Trump demands the U.S. pay no more for drugs than other countries … again

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

State Dept. review finds Biden bears some blame for Afghanistan failures

Researchers separate signal from noise in heart wearable data

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Man who had jail sentence commuted by Trump arrested again

entertainment

DOJ, FTC to increase scrutiny of all types of health care mergers

Eating disorder hotline's move to chatbot carried cost for volunteers

Stanford president to resign after investigation of research

Synthetic human embryos? Researchers say term is overblown

Why the Crimean Bridge is key to Russia's war in Ukraine

Trump got a 'target letter.' What is one and what does it mean?

knowledge

focus

explore

leisure time